Live WebinarTop 10 tips for direct composites
19 Jan 2021, 08:00 PM Berlin
On Demand WebinarInflammation and type 2 diabetes: pathogenesis and current treatment protocols
Marc Y. Donath MD
As a possible causal therapy, inflammatory mediators may help. This is supported by clinical studies showing that IL-1 antagonism decreases glycated hemoglobin. Furthermore, IL-1 antagonism prevents heart failure and cardiovascular diseases, the major complications of diabetes and may also prevent microvascular complications.
Lecture will cover the pathogenesis of type 2 diabetes, overview of current treatment protocols and potential of future anti-inflammatory treatment, including impact on periodontitis.